(Q37422824)

20 August 2017

1 reference

title

Update in chronic obstructive pulmonary disease 2008. (English)

1 reference

chronic obstructive pulmonary disease

20 August 2017

main subject

0 references

William MacNee

3

0 references

author name string

John D Maclay

series ordinal

1

1 reference

20 August 2017

Roberto A Rabinovich

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

20 August 2017

published in

1 reference

20 August 2017

volume

179

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

533-541

1 reference

Chronic obstructive pulmonary disease: a view from the NHLBI.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Longitudinal change in the BODE index predicts mortality in severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Increased systemic inflammation is a risk factor for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

C-reactive protein levels and survival in patients with moderate to very severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Systemic Inflammation and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Relationship between gastroesophageal reflux disease and COPD in UK primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Interaction between smoking and genetic factors in the development of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Autoantibodies in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Telomere shortening in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Increased p53 level, Bax/Bcl-x(L) ratio, and TRAIL receptor expression in human emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Dendritic cells in chronic obstructive pulmonary disease: new players in an old game

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Bronchodilator responsiveness in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Assessing the impact of pulmonary rehabilitation on functional status in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Efficacy of a cell phone-based exercise programme for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Implication of xanthine oxidase in muscle oxidative stress in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Quantitative computed tomography of lung parenchyma in chronic obstructive pulmonary disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Association of radiographic emphysema and airflow obstruction with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Airway wall thickness assessed using computed tomography and optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Predictors of outcomes in COPD exacerbation cases presenting to the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

A randomised, controlled trial of bosentan in severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Sildenafil treatment in COPD does not affect stroke volume or exercise capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Patterns of domestic activity and ambulatory oxygen usage in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Airway bypass improves the mechanical properties of explanted emphysematous lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Plasma Pro-Adrenomedullin But Not Plasma Pro-Endothelin Predicts Survival in Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Determinants of the Survival Benefit of Lung Transplantation in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

Increased activation of p38 MAPK in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200901-0134UP

10.1164/RCCM.200901-0134UP

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference